Open innovation in drug development EP News Bureau Dec 26, 2020 Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca shares insights on how greater transparency…
Why COVID-19 presents a golden opportunity to Indian pharma firms EP News Bureau Sep 16, 2020 Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca informs that with India Pharma Inc's…
Race to find a viable vaccine: Can Indian firms rise to the challenge? EP News Bureau Aug 17, 2020 Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to…
COVID–19 and its impact on India Pharma Inc EP News Bureau May 23, 2020 Juilee Dandekar – Sector Expert (Healthcare), Business Research & Advisory, Aranca, among other things, believes that India…